Similar articles

• Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?

  Greig MF, Rochow SB, Crilly MA, Mangoni AA. Greig MF, et al. Age Ageing. 2013 Jul;42(4):428-34. doi: 10.1093/ageing/aft041. Epub 2013 Apr 4. Age Ageing. 2013. PMID: 23557678 Review.
• ACP Journal Club: review: in older patients with AF or acute VTE, some DOACs reduce thrombotic events and major bleeding.

  White RH. White RH. Ann Intern Med. 2015 Nov 17;163(10):JC4. doi: 10.7326/ACPJC-2015-163-10-004. Ann Intern Med. 2015. PMID: 26571258 No abstract available.
• Venous thromboembolism and postoperative management of anticoagulation.

  Friedman SM, Uy JD. Friedman SM, et al. Clin Geriatr Med. 2014 May;30(2):285-91. doi: 10.1016/j.cger.2014.01.007. Epub 2014 Mar 4. Clin Geriatr Med. 2014. PMID: 24721368 Review.
• ACP Journal Club: after treating unprovoked PE with VKAs for 6 months, warfarin for 18 more months reduced a composite of VTE or major bleeding.

  Lipchik RJ. Lipchik RJ. Ann Intern Med. 2015 Nov 17;163(10):JC6. doi: 10.7326/ACPJC-2015-163-10-006. Ann Intern Med. 2015. PMID: 26571260 No abstract available.
• ACP Journal Club. Review: interventions to increase thromboprophylaxis do not benefit inpatients at risk for VTE.

  Baumann Kreuziger LM. Baumann Kreuziger LM. Ann Intern Med. 2013 Nov 19;159(10):JC10, JC11. doi: 10.7326/0003-4819-159-10-201311190-02010. Ann Intern Med. 2013. PMID: 24247688 No abstract available.